Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Frontiers in Neurology|March 26, 2024
Clinical presentation and diagnosis of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia: a literature analysis of case studiesSpyros Papapetropoulos, Jeffrey M Gelfand, Takuya Konno, et al.
Annals of Clinical and Translational Neurology|April 1, 2025
Phase 1, First-In-Human, Single-/Multiple-Ascending Dose Study of Iluzanebart in Healthy VolunteersAndreas Meier, Spyros Papapetropoulos, Andrew Marsh, et al.
Clinical Therapeutics|April 18, 2017
Incorporating Site-less Clinical Trials Into Drug Development: A Framework for ActionIrl B Hirsch, Joe Martinez, E Ray Dorsey, et al.
Frontiers in Neurology|June 30, 2017
Biometric Digital Health Technology for Measuring Motor Function in Parkinson's Disease: Results from a Feasibility and Patient Satisfaction StudyGeorgia Mitsi, Enrique Urrea Mendoza, Benjamin D Wissel, et al.
BMC Medical Informatics and Decision Making|December 22, 2018
Characterizing patient compliance over six months in remote digital trials of Parkinson's and Huntington diseaseShani Cohen, Zeev Waks, Jordan J Elm, et al.
Cancers|October 13, 2021
Reversal of Bortezomib-Induced Neurotoxicity by Suvecaltamide, a Selective T-Type Ca-Channel Modulator, in Preclinical ModelsCristina Meregalli, Yuri Maricich, Guido Cavaletti, et al.
Digital Biomarkers|February 26, 2020
Quantification of Motor Function in Huntington Disease Patients Using Wearable Sensor DevicesMark Forrest Gordon, Igor D Grachev, Itzik Mazeh, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|March 25, 2021
A Phase 2 Proof-of-Concept, Randomized, Placebo-Controlled Trial of CX-8998 in Essential TremorSpyros Papapetropoulos, Margaret S Lee, Stacey Versavel, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 22, 2018
Pridopidine, a clinic-ready compound, reduces 3,4-dihydroxyphenylalanine-induced dyskinesia in Parkinsonian macaquesTom H Johnston, Michal Geva, Lilach Steiner, et al.
Scientific Reports|August 17, 2016
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington diseaseMarta Garcia-Miralles, Xin Hong, Liang Juin Tan, et al.
Pageof 3